| B - Blood and Blood Forming Organs | | |
|
| B01 - Antithrombotic Agents | | |
|
| B01A - Antithrombotic Agents | | |
|
| B01AX - Other Antithrombotic Agents | | | The DDD for caplacizumab is 10 mg (P) based on the European labelling and equivalent to 11 mg in the USA labelling.
|
|
| B01AX05 - Fondaparinux | | Dose | Route of administration | Note |
|---|
| | P | |
|
|
